Wikipedia -WSS

Wikipedia

author：fashion 2025-10-01 00:05:28 - browse：74341

NICOLAS MAETERLINCK/BELGA MAG/AFP via Getty Images

LONDON — Novavax, the beleaguered maker of a Covid-19 vaccine, just got a boost of its own.

The French pharma company Sanofi on Friday said it had reached a licensing deal to sell Novavax’s Covid shot going forward as well as to try to combine the vaccine with Sanofi’s own flu shot. The pact includes a $500 million upfront payment, with up to $700 million more on the table if certain regulatory and launch milestones are reached.

While Novavax’s stock soared during the pandemic as the vaccine race was underway, the company failed to get its shot authorized in the U.S. market until July 2022, long after the makers of mRNA vaccines had reaped billions in sales. Sales have sputtered along since then, and last year, the Maryland-based company warned that that it may not be able to stay in business.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Change Healthcare payments predicted restored March 15

Wikipedia

WSS

The Readout: Lenmeldy, GLP

Readout Newsletter: Merck, Vertex, and Viking updates

How to bring more disabled researchers into academia

Covid vaccine financial winners and losers, from Pfizer to Novavax

Just how do doctors, lawmakers, and the public define abortion?

With psoriasis trial ahead, Alumis raises $259 million

hotspot

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

At least 13 dead in Texas as scorching temps continue

With psoriasis trial ahead, Alumis raises $259 million

Tori Bowie and the unacceptable rates of Black maternal death

Abortion pill Supreme Court ruling could impact entire drug industry

Heart attack and stroke risk calculators need revising

What it’s like to watch children die of measles

The high cost of giving birth even with insurance

Oprah kicked off a national conversation on obesity. Let's have it

Medicare details structure of new drug price negotiation program

Abortion pill case raises question: who can sue the FDA?

entertainment

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

The Readout: Lenmeldy, GLP

Amylyx ALS drug fails large clinical trial

Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

IVF, abortion rights issues kick off Biden’s State of the Union

RSV shot was 90% effective at preventing hospitalizations in kids

focus

hotspot

Wikipedia

Wikipedia